An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies
about
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeuticsDye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assemblyTransgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neuronsInsulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human AstrocytesMonitoring insulin aggregation via capillary electrophoresisUnraveling the early events of amyloid-β protein (Aβ) aggregation: techniques for the determination of Aβ aggregate size.Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicityA retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies.An Alzheimer's disease-relevant presenilin-1 mutation augments amyloid-beta-induced oligodendrocyte dysfunctionInduction of an inflammatory loop by interleukin-1β and tumor necrosis factor-α involves NF-kB and STAT-1 in differentiated human neuroprogenitor cells.Insight into amyloid structure using chemical probes.Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models.Involvement of Intracellular and Mitochondrial Aβ in the Ameliorative Effects of Huperzine A against Oligomeric Aβ42-Induced Injury in Primary Rat Neurons.Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method.Regulation of cyclic AMP response element-binding protein during neuroglial interactions.Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.Human induced pluripotent stem cells as a research tool in Alzheimer's disease.Mesenchymal Stem Cells Increase Hippocampal Neurogenesis and Neuronal Differentiation by Enhancing the Wnt Signaling Pathway in an Alzheimer's Disease Model.Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization.Organotypic vibrosections from whole brain adult Alzheimer mice (overexpressing amyloid-precursor-protein with the Swedish-Dutch-Iowa mutations) as a model to study clearance of beta-amyloid plaques.Evidence against a role of P-glycoprotein in the clearance of the Alzheimer's disease Aβ1-42 peptidesAβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.Amyloid β inhibits retinoic acid synthesis exacerbating Alzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonistFucoxanthin, a Marine Carotenoid, Attenuates β-Amyloid Oligomer-Induced Neurotoxicity Possibly via Regulating the PI3K/Akt and the ERK Pathways in SH-SY5Y Cells.Electrophysiological Techniques for Studying Synaptic Activity In Vivo.Neuroprotective actions of glucagon-like peptide-1 in differentiated human neuroprogenitor cells.Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease.
P2860
Q26822002-52F19800-E367-40B2-9FC4-9FEF30517E5CQ26852205-A0D273DF-66E7-47AC-A926-0F8DCB7C51CFQ33832139-00FFB02E-B2F0-4BBE-B03A-D9CB232C67DFQ33887259-5D9A738C-9AD2-4C29-84F4-4E333387A969Q34137156-CA1E80E6-9C6B-4674-8495-38115754924CQ34226572-BC3ECFB3-6211-4F92-9214-720188DCF034Q34450675-C47481C2-37DF-4F54-8D30-9D1B35E39411Q34518856-3D8BC781-4AAA-4AA0-AC7D-0FF86AA9D9BDQ34608237-186F5173-9709-4738-8530-565537099C75Q34903095-BA984F7A-958B-4F15-BBE0-DA3D43E99C3AQ34990429-C644DC98-943D-4D40-B973-E78B0954D670Q35319897-5C7ABE89-BB24-43CC-B2F8-808F346BABBDQ35646336-77D36B34-9579-47CB-B5D1-E225C448B7FBQ35804612-7BAF1BD4-F320-4DA3-809C-CD57949FAAE5Q35871299-22417BAA-62C9-4975-94A4-FBCD032E87EDQ38016898-212D2829-E7A6-4978-8CD5-2778B67EBC85Q38242621-4C935605-51B7-4B97-895D-82CBAA33C17FQ38643034-80A1C35F-4A0E-42D4-B73A-CFA131458F4FQ39235167-8ABCCE45-9098-4265-B78B-F37930760E70Q39418248-27C07D8D-48CA-4310-A531-7C7CB1F0C79DQ39440830-C393AE39-3369-4893-A36D-6B787731DBF7Q39885064-DF4CFEE1-881E-4EFA-AAE5-69DE63DD092FQ40506883-2D8DC022-765C-4081-83AB-F274FF776065Q40755303-8E56AA80-E8C3-44F5-BE86-4C8462A4FC6CQ41451368-C2D349F8-5625-42BA-BC70-33FBB2924EBFQ47931622-E422B36F-A1FB-44BF-B1C8-E312A6195B23Q48358888-8FDD56B7-7937-4C82-BF7C-3921A7916157Q49787603-8EA368EB-A6D4-448E-AD05-4D8FC8A7C363
P2860
An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An improved method for generat ...... in vitro neurotoxicity studies
@ast
An improved method for generat ...... in vitro neurotoxicity studies
@en
type
label
An improved method for generat ...... in vitro neurotoxicity studies
@ast
An improved method for generat ...... in vitro neurotoxicity studies
@en
prefLabel
An improved method for generat ...... in vitro neurotoxicity studies
@ast
An improved method for generat ...... in vitro neurotoxicity studies
@en
P2093
P2860
P1476
An improved method for generat ...... in vitro neurotoxicity studies
@en
P2093
Deborah A Ryan
Howard J Federoff
Wade C Narrow
William J Bowers
P2860
P304
P356
10.1016/J.JNEUMETH.2010.05.001
P577
2010-05-07T00:00:00Z